Viatris, Inc. (VTRS)
16.30
+0.04
(+0.25%)
USD |
NASDAQ |
May 27, 16:00
16.36
+0.06
(+0.37%)
After-Hours: 18:43
Viatris Cash from Investing (Quarterly) : 277.40M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | 785.00M |
| Theravance Biopharma, Inc. | 52.59M |
| Bristol Myers Squibb Co. | -131.00M |
| Indivior Pharmaceuticals, Inc. | -19.00M |
| Eli Lilly & Co. | -3.916B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 388.30M |
| Cash from Financing (Quarterly) | -203.80M |
| Free Cash Flow | 1.643B |
| Free Cash Flow Per Share (Quarterly) | 0.2267 |
| Free Cash Flow to Equity (Quarterly) | 354.30M |
| Free Cash Flow to Firm (Quarterly) | 180.16M |
| Free Cash Flow Yield | 8.64% |